ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,282.16
0.42%
Dow Jones
39,112.16
-0.76%
Gold vs US Dollar
2,316.84
-0.17%
Brent Oil
84.975
0.94%
Bitcoin
61,376.59
-0.70%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pulse Biosciences Inc (PLSE)

  7. Pulse Biosciences Inc (PLSE) News

Pulse Biosciences (PLSE)

Pulse Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PLSE
DateTimeSourceHeadlineSymbolCompany
07/06/202421:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
04/06/202421:05Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NASDAQ:PLSEPulse Biosciences Inc
04/06/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
03/06/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PLSEPulse Biosciences Inc
31/05/202421:18Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:PLSEPulse Biosciences Inc
28/05/202422:19Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PLSEPulse Biosciences Inc
22/05/202419:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
22/05/202419:03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PLSEPulse Biosciences Inc
20/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
20/05/202421:05Business WirePulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000NASDAQ:PLSEPulse Biosciences Inc
16/05/202413:00Business WirePulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual MeetingNASDAQ:PLSEPulse Biosciences Inc
15/05/202414:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
14/05/202421:05Business WirePulse Biosciences Enhances Executive Leadership TeamNASDAQ:PLSEPulse Biosciences Inc
09/05/202414:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
09/05/202413:00Business WirePulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode SystemNASDAQ:PLSEPulse Biosciences Inc
07/05/202421:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PLSEPulse Biosciences Inc
07/05/202421:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
07/05/202421:05Business WirePulse Biosciences Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
02/05/202413:00Business WirePulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000NASDAQ:PLSEPulse Biosciences Inc
24/04/202421:05Business WirePulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024NASDAQ:PLSEPulse Biosciences Inc
28/03/202420:12Business WirePulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial ResultsNASDAQ:PLSEPulse Biosciences Inc
28/03/202420:10Business WirePulse Biosciences Announces Plans to Initiate a Rights OfferingNASDAQ:PLSEPulse Biosciences Inc
14/03/202420:05Business WirePulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024NASDAQ:PLSEPulse Biosciences Inc
11/03/202413:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
08/03/202418:17Business WirePulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode SystemNASDAQ:PLSEPulse Biosciences Inc
14/02/202414:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
14/02/202413:00Business WirePulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility StudyNASDAQ:PLSEPulse Biosciences Inc
31/01/202413:00Business WirePulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF SymposiumNASDAQ:PLSEPulse Biosciences Inc
09/01/202414:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
02/01/202414:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PLSEPulse Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:PLSE

Your Recent History

ASX
NIM
Nimy Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved